Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved In Japan

... Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company''s country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in combination with REBETOL(R) (ribavirin) Capsules -- the treatment of chronic hepatitis C in adult patients other than those with genotype 1 virus and high viral load... click link for more info. ...